Mirae Asset Global Investments Co., Ltd. Ascendis Pharma A/S Transaction History

Mirae Asset Global Investments Co., Ltd.

  • $22.5 Billion
  • Q3 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 7,141 shares of ASND stock, worth $926,973. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,141
Previous 8,216 13.08%
Holding current value
$926,973
Previous $1.12 Million 4.82%
% of portfolio
0.0%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024
SELL
$113.0 - $153.43 $121,475 - $164,937
-1,075 Reduced 13.08%
7,141 $1.07 Million
Q2 2024

Jul 30, 2024
SELL
$121.07 - $153.67 $612,614 - $777,570
-5,060 Reduced 38.11%
8,216 $1.12 Million
Q1 2024

May 01, 2024
SELL
$123.45 - $159.4 $88,019 - $113,652
-713 Reduced 5.1%
13,276 $2.01 Million
Q4 2023

Jan 24, 2024
BUY
$86.1 - $127.36 $16,014 - $23,688
186 Added 1.35%
13,989 $1.76 Million
Q3 2023

Oct 26, 2023
BUY
$86.5 - $103.97 $79,666 - $95,756
921 Added 7.15%
13,803 $1.29 Million
Q2 2023

Aug 10, 2023
SELL
$69.96 - $97.84 $280,189 - $391,849
-4,005 Reduced 23.72%
12,882 $1.15 Million
Q1 2023

May 04, 2023
SELL
$104.9 - $126.78 $298,650 - $360,942
-2,847 Reduced 14.43%
16,887 $1.81 Million
Q4 2022

Feb 09, 2023
SELL
$99.42 - $131.97 $373,322 - $495,547
-3,755 Reduced 15.99%
19,734 $2.41 Million
Q3 2022

Nov 10, 2022
SELL
$84.03 - $110.23 $503,759 - $660,828
-5,995 Reduced 20.33%
23,489 $2.43 Million
Q2 2022

Jul 26, 2022
BUY
$78.08 - $117.61 $96,584 - $145,483
1,237 Added 4.38%
29,484 $2.74 Million
Q1 2022

May 10, 2022
SELL
$102.18 - $135.75 $106,369 - $141,315
-1,041 Reduced 3.55%
28,247 $3.32 Million
Q4 2021

Feb 08, 2022
SELL
$127.1 - $169.66 $46,772 - $62,434
-368 Reduced 1.24%
29,288 $3.94 Million
Q3 2021

Nov 15, 2021
BUY
$112.67 - $176.92 $47,096 - $73,952
418 Added 1.43%
29,656 $4.73 Million
Q2 2021

Aug 11, 2021
SELL
$121.62 - $145.29 $309,887 - $370,198
-2,548 Reduced 8.02%
29,238 $3.85 Million
Q1 2021

May 13, 2021
BUY
$124.92 - $173.33 $807,982 - $1.12 Million
6,468 Added 25.55%
31,786 $4.1 Million
Q4 2020

Feb 10, 2021
BUY
$151.2 - $182.76 $27,669 - $33,445
183 Added 0.73%
25,318 $4.22 Million
Q3 2020

Nov 12, 2020
BUY
$134.29 - $154.32 $667,824 - $767,433
4,973 Added 24.67%
25,135 $3.88 Million
Q2 2020

Aug 11, 2020
SELL
$110.87 - $156.01 $137,035 - $192,828
-1,236 Reduced 5.78%
20,162 $2.98 Million
Q1 2020

May 12, 2020
BUY
$97.01 - $145.11 $369,899 - $553,304
3,813 Added 21.68%
21,398 $2.41 Million
Q4 2019

Feb 12, 2020
BUY
$91.45 - $139.12 $555,284 - $844,736
6,072 Added 52.74%
17,585 $2.45 Million
Q3 2019

Nov 12, 2019
SELL
$95.8 - $118.9 $9,867 - $12,246
-103 Reduced 0.89%
11,513 $1.11 Million
Q2 2019

Aug 13, 2019
SELL
$107.11 - $132.09 $207,257 - $255,594
-1,935 Reduced 14.28%
11,616 $1.34 Million
Q1 2019

May 13, 2019
BUY
$62.15 - $129.99 $140,272 - $293,387
2,257 Added 19.98%
13,551 $1.6 Million
Q4 2018

Feb 11, 2019
BUY
$55.16 - $69.67 $157,206 - $198,559
2,850 Added 33.75%
11,294 $708,000
Q3 2018

Nov 13, 2018
BUY
$63.77 - $76.28 $325,673 - $389,561
5,107 Added 153.04%
8,444 $598,000
Q2 2018

Aug 14, 2018
BUY
$58.55 - $73.92 $1,815 - $2,291
31 Added 0.94%
3,337 $222,000
Q1 2018

May 10, 2018
BUY
$38.98 - $68.04 $128,867 - $224,940
3,306 New
3,306 $216,000

Others Institutions Holding ASND

# of Institutions
243
Shares Held
58.8M
Call Options Held
250K
Put Options Held
377K
View Full List

About Ascendis Pharma A/S

ASND Quotes by TradingView
  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $7.24B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email